“In the near to medium term, clearer regulations will likely boost institutional participation, leading to improvements in ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of ...

Japan's inflation picked up in January, with core inflation reaching 3.2% year-on-year, surpassing expectations. The rising ...

And households are hating it. Part of the problem is that most of the inflation from which Japan is suffering comes from ...

The Japanese yen soared to a 2.5-month high on Friday, strengthening to 149.285 per dollar, following a sharp rise in Japans ...

The yen retreated on Friday from a 2-1/2 month high hit on a jump in Japanese inflation, while the dollar was set for its third weekly drop in a ...

With geopolitical risk now feeding directly into FX price action, traders will be glued to every headline out of Washington, ...

Data showed core inflation in Japan rose to 3.2% in January, up from 3% in December, exceeding forecasts of 3.1%. Headline inflation also increased to 4%, up from 3.6%, marking the highest level in ...

Global equity markets fell while gold prices surged on Thursday, with traders marking one month since U.S. President Donald ...

Consumer inflation in Tokyo likely slowed down in February as the government reinstated steps to ease the burden from energy ...

Japans core consumer price index (CPI) rose 3.2% year-over-year in January, reaching a 19-month high, exceeding the market ...